US 10874648
Methods for the administration of certain VMAT2 inhibitors
granted A61KA61K31/4375A61K31/4525
Quick answer
US patent 10874648 (Methods for the administration of certain VMAT2 inhibitors) held by Neurocrine Biosciences, Inc. expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/4375, A61K31/4525, A61K31/4709, A61K31/4745